Editor’s Note (January 2026): Following the passing of Bob Weir at age 78, we’re resurfacing this archival High Times piece, first published in 2019, as a tribute to his life, curiosity, and lasting influence on music, culture, and consciousness. Weir was never just a guitarist or songwriter. He was a seeker. A listener. Someone deeply
From pleasure and connection to harm reduction and policy failure, a look at what decades of drug enforcement got wrong about human behavior. The conversation around drugs has long been framed by cost. Policymakers calculate the billions lost every year to productivity gaps, hospitalizations, law enforcement and incarceration. The U.S. alone spends an estimated $193 billion
Cannabis is having one of those moments again. Headlines are flying. Group chats are buzzing. Stocks are moving. Politicians are lining up to take credit. After more than fifty years in Schedule I, cannabis is finally being acknowledged by the federal government as having medical value. That alone is historic. It’s the U.S. government, at
A just-for-fun poll yielded a solid lineup of greatness, including Bodhi, CSI Humboldt, Capulator, and Archive Seed Bank Three reclusive California weed legends and a Spanish “automatic” seed factory took top honors in a new, Top 50 Greatest Breeders of 2025 poll. The Top 50 list came from polling data published on the Fire Follower
When a government labels something “drug enforcement,” it can widen the map of what becomes justifiable. Using Maduro’s seizure as the case study, this article breaks down the charges, the weak points critics see in the legal architecture, and why the war on drugs keeps doubling as a foreign-policy tool. How deep does the rabbit
Something unusual is happening in cannabis policy right now. Groups that almost never agree on anything are suddenly speaking the same language. Major medical organizations, Trump-aligned political operatives, and even cannabis industry advocates, all of them are applauding the same development: marijuana’s move toward Schedule III. At first glance, it reads like progress. Maybe it
I’ve spent years watching cannabis content evolve, and most of it follows the same rhythm. Fast edits. Trending sounds. Quick hits. Then I came across Cough Creative, and something felt different before I could even explain why. The pacing was calm. The visuals felt familiar. It didn’t rush you. It invited you in. Ally Train
The science of sleep: an ephemeral paradise. Colors, flashes, digressions, backdrops, and shapes. Raw intensity. Dreams within dreams. There’s an architecture in the arms of Morpheus. And for frequent cannabis smokers, a joint can act as the great conciliator. Light up, smoke, and drift off. But, but, but: what happens to sleep when regular pot
The PhilaDelic Fall Forum laid out a roadmap for wider use of ibogaine and mushrooms to treat addiction and depression as stigma fades. Leading chemists, psychiatrists, treatment professionals, academics and activists gathered to expand the medical use of psychedelic drugs. After spending the day with therapists, scientists and patients at the PhilaDelic Fall Forum, it
Kentucky’s first medical cannabis dispensary sold out its entire inventory in just seven days, then temporarily closed, a fast start that highlights both intense statewide demand and the tight supply constraints of a brand-new program. The Post Dispensary in Beaver Dam opened December 13 and exhausted its limited stock by December 20, owner Trip Hoffman
